Snowden Capital Advisors LLC Bristol Myers Squibb CO Transaction History

Snowden Capital Advisors LLC

  • $3.31 Billion
  • Q2 2024

A detailed history of Snowden Capital Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 147,705 shares of BMY stock, worth $7.86 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
147,705
Previous 151,878 2.75%
Holding current value
$7.86 Million
Previous $8.24 Million 25.52%
% of portfolio
0.19%
Previous 0.26%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$40.25 - $52.99 $167,963 - $221,127
-4,173 Reduced 2.75%
147,705 $6.13 Million
Q1 2024

May 15, 2024
BUY
$47.98 - $54.4 $5.61 Million - $6.37 Million
117,023 Added 335.74%
151,878 $8.24 Million
Q4 2023

Feb 14, 2024
SELL
$48.48 - $57.85 $341,880 - $407,958
-7,052 Reduced 16.83%
34,855 $1.79 Million
Q3 2023

Nov 14, 2023
SELL
$57.89 - $64.73 $924,387 - $1.03 Million
-15,968 Reduced 27.59%
41,907 $2.43 Million
Q2 2023

Aug 14, 2023
BUY
$63.71 - $70.74 $684,372 - $759,889
10,742 Added 22.79%
57,875 $3.7 Million
Q1 2023

May 15, 2023
BUY
$65.71 - $74.53 $327,432 - $371,382
4,983 Added 11.82%
47,133 $3.27 Million
Q4 2022

Feb 13, 2023
SELL
$68.48 - $81.09 $13,901 - $16,461
-203 Reduced 0.48%
42,150 $3.03 Million
Q3 2022

Nov 09, 2022
SELL
$0.13 - $76.84 $180 - $106,653
-1,388 Reduced 3.17%
42,353 $3.01 Million
Q2 2022

Aug 12, 2022
BUY
$72.62 - $79.98 $98,109 - $108,052
1,351 Added 3.19%
43,741 $3.37 Million
Q1 2022

May 16, 2022
BUY
$61.48 - $73.72 $1.39 Million - $1.66 Million
22,558 Added 113.75%
42,390 $3.1 Million
Q4 2021

Feb 14, 2022
BUY
$53.63 - $62.52 $1.06 Million - $1.24 Million
19,832 New
19,832 $1.24 Million
Q3 2021

Feb 05, 2024
SELL
$59.17 - $69.31 $1.35 Million - $1.58 Million
-22,859 Reduced 54.55%
19,048 $1.13 Billion
Q2 2021

Jan 08, 2024
BUY
$61.91 - $67.42 $78,130 - $85,084
1,262 Added 7.43%
18,245 $1.22 Billion
Q1 2021

Jan 08, 2024
BUY
$59.34 - $66.74 $295,275 - $332,098
4,976 Added 41.44%
16,983 $1.07 Billion
Q4 2020

Jan 08, 2024
BUY
$57.74 - $65.43 $80,489 - $91,209
1,394 Added 13.13%
12,007 $745 Million
Q3 2020

Jan 08, 2024
SELL
$57.43 - $63.64 $57,946 - $64,212
-1,009 Reduced 8.68%
10,613 $640 Million
Q2 2020

Jan 08, 2024
SELL
$54.82 - $64.09 $219,992 - $257,193
-4,013 Reduced 25.67%
11,622 $683 Million
Q1 2020

Jan 08, 2024
BUY
$46.4 - $67.43 $282,204 - $410,109
6,082 Added 63.67%
15,635 $871 Million
Q4 2019

Jan 30, 2024
BUY
$49.21 - $64.19 $120,220 - $156,816
2,443 Added 34.36%
9,553 $613 Million
Q4 2019

Jan 08, 2024
BUY
$49.21 - $64.19 $120,220 - $156,816
2,443 Added 34.36%
9,553 $613 Million
Q3 2019

Jan 30, 2024
BUY
$42.77 - $50.71 $82,674 - $98,022
1,933 Added 37.34%
7,110 $361 Million
Q3 2019

Jan 08, 2024
BUY
$42.77 - $50.71 $124,246 - $147,312
2,905 Added 69.08%
7,110 $361 Million
Q2 2019

Jan 30, 2024
SELL
$44.62 - $49.34 $1.64 Million - $1.81 Million
-36,730 Reduced 87.65%
5,177 $235 Million
Q2 2019

Jan 08, 2024
SELL
$44.62 - $49.34 $252,192 - $278,869
-5,652 Reduced 57.34%
4,205 $235 Million
Q1 2019

Jan 08, 2024
BUY
$45.12 - $53.8 $21,341 - $25,447
473 Added 5.04%
9,857 $470 Million
Q4 2018

Jan 08, 2024
BUY
$48.76 - $63.23 $141,306 - $183,240
2,898 Added 44.68%
9,384 $488 Million
Q3 2018

Jan 08, 2024
BUY
$55.19 - $62.25 $83,502 - $94,184
1,513 Added 30.42%
6,486 $403 Million
Q2 2018

Jan 08, 2024
BUY
$50.53 - $62.98 $28,903 - $36,024
572 Added 13.0%
4,973 $275 Million
Q1 2018

Jan 08, 2024
BUY
$59.92 - $68.98 $63,335 - $72,911
1,057 Added 31.61%
4,401 $278 Million
Q4 2017

Jan 08, 2024
BUY
$59.94 - $65.35 $200,439 - $218,530
3,344 New
3,344 $205 Million
Q2 2017

Jan 08, 2024
SELL
N/A
-3,946 Closed
0 $0
Q1 2017

Jan 08, 2024
SELL
N/A
-37,961
3,946 $215 Million

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email